Akero Therapeutics, Inc.: 25-NSE filed Dec 9, 2025

Form type

25-NSE

Filing date

Dec 9, 2025

Accession number

0001354457-25-001233

Filer

Akero Therapeutics, Inc. (CIK 1744659)